Cite
HARVARD Citation
Aytes, A. et al. (2018). NSD2 is a conserved driver of metastatic prostate cancer progression. Nature communications. 9 (1), pp. 1-14. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aytes, A. et al. (2018). NSD2 is a conserved driver of metastatic prostate cancer progression. Nature communications. 9 (1), pp. 1-14. [Online].